Clinical Trial

A Study of SYS6010 in Combination With SYH2051 in Patients With Advanced Colorectal Cancer and Other Gastrointestinal Tumors

Name: A Study of SYS6010 in Combination With SYH2051 in Patients With Advanced Colorectal Cancer and Other Gastrointestinal Tumors — clinical trial record (NCT07104877)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Active, Not Recruiting

View on ClinicalTrials.gov →

Summary

This study is an open-label, non-randomized trial design, including a dose escalation phase and a dose expansion phase, to evaluate the safety, tolerability and preliminary anti-tumor activity of SYS6010 in combination with SYH2051 in patients with advanced gastrointestinal tumors.

Trial Details

NCT Number	NCT07104877
Lead Sponsor	Fujian Cancer Hospital
Conditions	Colorectal Cancer, Gastric Cancer (GC), Gastrointestinal Tumors
Enrollment	25 participants
Start Date	2024-04-18
Primary Completion	2024-11-01 (estimated)
Study Completion	2026-04-30 (estimated)
Updated on ClinicalTrials.gov	2025-08-05